TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Sonic Healthcare Limited ( (AU:SHL) ).
Sonic Healthcare Limited announced a significant leadership transition as Dr. Colin Goldschmidt retires, with Dr. Jim Newcombe stepping in as the new Managing Director and CEO. Under Goldschmidt’s leadership, Sonic expanded globally and became the third largest pathology player worldwide. The company reported strong financial performance for 2025, with revenue reaching A$9.6 billion and a net profit of A$514 million, and anticipates continued growth in 2026. The appointment of Evangelos Kotsopoulos as COO and the addition of Nicola Wakefield Evans to the Board highlight Sonic’s focus on strengthening its executive team and board diversity. Sonic also emphasized its ongoing commitment to sustainability and corporate responsibility, with progress in assessing climate-related risks and human rights management.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.80 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited is a leading global provider in the medical diagnostics industry, offering high-quality pathology and laboratory services. The company has established a strong market presence in seven countries, driven by its commitment to medical leadership and excellence in service.
Average Trading Volume: 1,710,748
Technical Sentiment Signal: Sell
Current Market Cap: A$10.38B
For an in-depth examination of SHL stock, go to TipRanks’ Overview page.